Lymphoid precursor cells adhere to two different sites on fibronectin by unknown
Lymphoid Precursor Cells Adhere to Two Different Sites on Fibronectin 
Paolo Bernardi,* Vikram P. Patel,* and Harvey E  Lodish*~ 
*  Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142; 
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 
Abstract.  Several precursor lymphoid cell lines, 
blocked at specific stages of differentiation, adhere 
specifically to fibronectin in vitro. Whereas the Ba F3 
cell line, which has both immunoglobulin heavy- and 
light-chain genes in germline configuration, interacts 
with the arg-gly-asp-containing cell-binding domain of 
fibronectin, the B-committed line PD 31, which is 
undergoing rearrangement of immunoglobulin light- 
chain genes, does not. Accordingly the Ba F3, but not 
the putative PD 31  surface fibronectin receptor, binds 
to an affinity matrix containing the  ll5-kD cell-binding 
domain of fibronectin. PD 31  cells recognize a differ- 
ent domain of the fibronectin molecule, which is con- 
rained within the carboxy terminal segment possessing 
a  high-affinity binding site for heparin.  A  polyclonal 
antibody raised against the fibronectin receptor of 
mouse erythroleukemic cells inhibits adhesion of these 
lymphoid lines to fibronectin. It precipitates two major 
species of 140 and 70 kD from surface-radioiodinated 
Ba F3 cells and species of 140 and  120 kD from PD 
31  cells. We propose that the two types of cells 
express different fibronectin receptors mediating sub- 
strate adhesion, and suggest that receptor(s)  with 
different specificity might be expressed in the course 
of B cell maturation. Because we show that these 
adhesion properties are shared by normal bone mar- 
row lymphoid precursors,  we infer that these receptors 
may play a  role in normal lymphopoiesis. 
W 
'I~E RE  AS the molecular mechanisms underlying im- 
munoglobulin gene rearrangements are now under- 
stood at least in outline (Tonegawa,  1983) and the 
complex process  of mature lymphocyte recirculation and 
homing is being actively investigated (Gowans and Knight, 
1964; reviewed by Gallatin et al., 1986), remarkably little is 
known about  the processes  of membrane remodeling in- 
volved in the maturation of lymphoid precursors and in their 
release into the circulation. A link between successful rear- 
rangement of antigen receptor genes and plasma membrane 
remodeling is likely, in that only a fraction of the cells pro- 
duced daily in the maturative compartments survives and is 
released into the circulation (Gallatin et al.,  1986). 
In  the  normal  adult mammal,  hematolymphopoiesis is 
confined to the bone marrow, which provides a unique induc- 
tive microenvironment responsible for the ordered prolifera- 
tion and differentiation of all the cell lineages whose mature 
progeny is found in the circulation (Zuckerman and Rhodes, 
1985). Both stromal cells (Dexter et al., 1985) and the extra- 
cellular matrix (Zuckerman and Rhodes,  1985) play key 
roles in maintaining a balanced hemopoiesis, but the require- 
ment for specific cellular and matrix factors is less under- 
stood. 
Recent work has  shown that both normal  reticulocytes 
(Patel et al.,  1985) and murine erythroleukemia cells (Patel 
and Lodish,  1984, 1986; Giancotti et al.,  1986) possess a 
140-kD fibronectin receptor recognizing the arg-gly-asp se- 
quence  within  the  cell-binding  domain  of  fibronectin 
(Pierschbacher et al.,  1982; Yamada and Kennedy, 1984). 
Loss or modification of this receptor protein is responsible 
for the loss of adhesion to fibronectin observed in differen- 
tiated cells (Patel and Lodish, 1986). This receptor is similar 
in binding specificity to those described in human osteosar- 
coma cells (Pytela et al., 1985), mouse fibroblasts (Giancotti 
et al., 1985), platelets (Gardner and Hynes, 1985; Pytela et 
al.,  1986) and chick embryo fibroblasts  (Horwitz et  al., 
1985; Akiyama et al.,  1986). 
Here we show that several pre-B lymphoid cell lines grown 
in culture attach specifically to fibronectin in vitro, and pro- 
vide evidence suggesting that this process  is mediated by 
receptors that exhibit immunologic cross-reactivity with the 
erythroid receptor.  At variance from uncommitted B  cell 
precursors,  which interact with the arg-gly-asp fibronectin 
recognition sequence, pre-B cells undergoing the rearrange- 
ment of heavy- and/or light-chain genes recognize a different 
region  of the  fibronectin molecule  which  is  part  of the 
carboxy-terminal end containing the high-affinity binding 
site for heparin. We suggest that fibronectin receptors with 
different specificity are expressed in the course of pre-B cell 
maturation. Because we also show that a significant fraction 
of normal bone marrow pre-B cells specifically adheres to 
fibronectin and to its carboxy-terminal fragment containing 
the high-affinity site for heparin but not the arg-gly-asp rec- 
ognition sequence, we infer that multiple receptors may play 
a role in normal lymphoid precursor cell adhesion to the ex- 
tracellular matrix. 
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Ig genes  Adherent cells 
Cell type  HC  LC  Surface Ig  Fibronectin  BSA 
%  % 
Ba F3  G  G  -  40.5  5.0 
38 B9  pR  G  -  35.9  10.5 
PD  31  R  pR  -  66.3  6.4 
70 Z/3  R  R  -  75.4  31.0 
WEHI 231  R  R  +  31.5  18.1 
MPC  11  R  R  -  21.3  2.8 
Circulating B  lymphocytes*  R  R  +  <0.5  <0.5 
MEL  -  -  -  83.9  5.3 
Cells were assayed for attachment to fibronectin  (5 p.g/cm  2) or BSA (2%) on 35-mm diameter plastic petri dishes. The entries under Ig genes and Surface Ig refer 
to the configuration of genes for immanoglobulin  heavy chains (HC), light chains (LC), and to the presence (+) or absence (-) of surface Ig, respectively. Abbrevi- 
ations: G, gerrrdine;  pR, partially rearranged; R, rearranged. The cells are listed in order of their level of commitment along the B cell lineage. MEL cells were 
included as a positive control. 
* Identified  by immunofluorescence on a monocyte-depleted mononuclear fraction from peripheral blood. 
Materials and Methods 
Materials 
Histopaque 1077, Nonidet-P40, cyanogen bromide-activated Sepharose 4B, 
and phenyimethylsulphonyl fluoride (PMSF) were purchased from Sigma 
Chemical Co. (St. Louis, MO). Laminin was from Collaborative Research 
(Lexington, MA), Collagen type I from Flow Laboratories, Inc. (McLean, 
VA),  N-acetyl-D-glucosamine from  Pfanstiehl  Laboratories  (Waukegan, 
IL), wheat germ agghitihin-agarose from E. Y. Laboratories (San Mateo, 
CA), DEAE-Sepharose from Pharmacia Fine Chemicals (Piscataway, N J), 
octyl-[i-o-glucopyranoside from Calbiochem-Behring Corp.  (San Diego, 
CA),  and the synthetic peptides gly-arg-gly-asp-ser-pro-cys, gly-arg-gly- 
asp-ser-pro, and gly-arg-glu-asp-ser-pro from Peninsula Laboratories, Inc. 
(Belmont, CA). The rat RA3-6B2 monoclonal antibody was a generous gift 
of Dr. Robert Coffman (DNAX, Palo Alto, CA). Rabbit and goat IgG, goat 
affinity-purified IgG against mouse Ig, and F(ab)2  fluorescein-conjugated 
goat anti-rat and rabbit anti-goat IgG were all from Cappel Laboratories 
(Malvern, PA); monoclonal antibodies against defined regions of fibronec- 
tin were purchased from Mallinckrodt Inc. (St.  Louis, MO).  Fibronectin 
was isolated from outdated human plasma by  gelatin-Sepharose affinity 
chromatography according  to  Ruoslahti et  al.,  (1982),  and  the  115-kD 
chymotryptic fragment containing the cell attachment domain was prepared 
according to Ruoslahti et al. (1981) and purified to >95% homogeneity as 
described (Patel and Lodish, 1986).  A heparin-binding chymotryptic frag- 
ment of fibronectin was obtained by passing the chymotryptic digest in 0.15 
M NaCI, 20 mM Tris, 1 mM CaC12 (pH 7.4) through a heparin-Sepharose 
column, and eluting the bound material with 1 M NaC1 in the same buffer. 
A SDS-PAGE analysis of the eluted material is shown in the inset to Fig. 4 a. 
Cell Cultures 
Ba F3 cells, kindly provided by Dr. Bernard Mathey-Prevot of the White- 
head Institute, were grown in RPMI 1640 medium supplemented with 10% 
heat-inactivated fetal calf serum (FCS) and 10% of RPMI 1640 medium con- 
ditioned by the interleukin 3 (IL-3)-producing line WEHI 3. 38 B9 (Air et 
al., 1981), PD 31 (Lewis et al., 1982), 70 Z/3 (Paige et al., 1978), and WEHI 
231 (Ralph, 1979) cells were grown in RPMI 1640 supplemented with 10% 
heat-inactivated FCS and 5.8  x  10  -3 M  2-mercaptoethanol. MEL (Friend 
et al., 1971) and MPC U cells (Kuehl and Scharff, 1974) were grown in DME 
supplemented with  13%  inactivated FCS.  HepG2  and Chinese hamster 
ovary (CHO) cells were grown as monolayers in DME or Ham's F12, respec- 
tively, plus 10%  heat-inactivated FCS,  and detached with trypsin/EDTA 
(Gibco, Grand Island, NY). All growth media were supplemented with anti- 
biotics. A brief description of the lymphoid lines used in this study is given 
in Table I. 
Isolation of  Bone Marrow Cells 
Bone marrow cells were prepared from 4-5-woold BALB/c mice from Dr. 
R. Jaenisch's breeding colony at the Whitehead Institute. Femurs were iso- 
lated as described by Oliver and Goldstein (197g), and hone marrow cells 
were obtained by flushing the femurs with DME/5%  FCS plus 5 mM Na- 
EDTA, and washed once in DME/5%  FCS. A mononuclear fraction was 
prepared by standard Ficoll gradient centrifugation using Histopaque 1077. 
Cells  at  the  DME-Ficoll  interphase  were  collected,  washed  once  in 
DME/5 % FCS, and depleted of monocytes/macrophages  by incubation for 
1 h at 37°C in a tissue culture grade 60-mm diameter plastic dish (Falcon 
Labware, Oxnard, CA). Nonadherent cells were collected, and the dishes 
were flushed with a gentle stream of medium to detach loosely adherent cells 
which were pooled with the unattached fraction. This preparation contains 
40-50% cells positive for the B lineage-restricted antigen B-220 (Coffman, 
1982),  as  assayed by  indirect  immunofluorescence. Lymphocytes from 
mouse peripheral blood were isolated with the same procedure from 4-mo- 
old mice of the same strain. 
Attachment Assays 
Adhesion assays of cells grown in suspension were carded out in either 35- 
mm diameter plastic petri dishes (Falcon Labware) or in 6-mm diameter, 
96-well polystyrene plates (Linbro, Flow Laboratories, Inc.) exactly as de- 
scribed by Patel and Lodish (1984,  1986).  Each experimental point is the 
average of triplicate (35-mm dishes) or quadruplicate determinations (96- 
well plates), and the standard deviation was within 10%. Adhesion assays 
of bone marrow cells and peripheral lymphocytes were carried out in 60- 
nun diameter petri dishes coated with the indicated amounts of fibronectin 
or its heparin-binding fragment, where 8  x  106 cells per dish in 4  ml of 
DME/5% FCS were incubated at 37°C for 60 min. Nonadherent cells were 
collected and the dishes were rimed twice with 2 ml of the same medium, 
which was pooled with the nonadherent cells. Adherent cells were detached 
by incubation in DME/5% FCS plus 5 mM EDTA at 4°C for 20 min. Both 
adherent  and  nonadherent  cells  were  counted  with  a  Coulter  counter 
(Coulter Electronics Inc., Hialeah, FL), and further analyzed by indirect 
immunofluorescence. 
Immunofluorescence 
Cells were washed once in Hank's balanced salt solution supplemented with 
20 mM Hepes and 1% bovine serum albumin (BSA), resuspended in 1 ml 
of the same solution, and reacted for 15 min on ice with (a) 1 mg/ml control 
IgG of the same species as that of the secondary fluorescent antibody, (b) 
RA3-6B2 rat monoclonal antibody (Coffman, 1982) or affinity-purified IgG 
fraction of goat anti-mouse Ig, and (c) fluoresceinated F(abh fragments of 
either goat anti-rat or rabbit anti-goat IgG. Cells were washed with Hank's 
balanced salt solntion/20 mM Hepes/l% BSA after each step, and finally 
resuspended in 0.15 M  NaC1, 10 mM Tris-HCl, 0.2% NaN3 (pH 8.0).  Flu- 
orescent cells were counted with a Zeiss Ill RS epifluorescence microscope 
(Carl Zeiss, Inc., Thornwood, NY). At least 200 cells were counted, and 
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treated with the primary antibody. 
Surface lodination and lmmunoprecipitation 
Cells were surface-labeled with  125I-sodium iodide (100 mCi/ml,  Amer- 
sham Corp., Arlington Heights, IL) according to Sefton et al. (1973), and 
extracted with 0.15 M NaCl,  10 mM Na-phosphate, 1 mM CaCl2,  1 mM 
MgClz, 2  mM PMSE  l  mM Nal, 0.2 M  octylglucoside (pH 7.4)  as de- 
scribed by Patel and Lxxiish 0986).  In this study, we used 1 mCi of 125I- 
and  1 ml of extraction buffer per 5  x  l0  7 cells with the exception of the 
experiment reported in Fig. 5, where 3 mCi of 125I- was used. For immu- 
noprecipitation, 0.5 ml of total  cell extract or affinity-purified fibronectin 
receptor was added to 1 ml of 0.15 M  NaCl, 20 mM Tris-HCl pH 7.5,  l 
mM  CaCl2,  2  mM  PMSE  2  mg/ml BSA,  1%  NP 40.  Then,  30  p.l of 
preimmune or antifibronectin receptor antiserum was added, and the sam- 
ples were incubated for 90 min at 4°C on a rocking platform. Then 50 Ixl 
per sample of 10% Staphylococcus aureus protein A was added, and the in- 
cubation was continued for a further 30 min. The samples were centrifuged 
for 20 s at 13,000 g, and the precipitates were washed sequentially with the 
same buffer,  then with 0.15 M  NaCl,  20 mM Tris-HCl, pH Z5,  1 mM 
CaCI2,  1 mM PMSE 0.1% NP 40, and finally with 0.15 M NaCl, 20 mM 
Tris-HCl,  pH  7.5. The  washed precipitates were dissolved in  Laemmli 
(1970) gel sample buffer,  boiled for 3 min, and centrifuged at 13,000 g for 
1 min at room temperature. The supernatants were subjected to SDS-PAGE 
as specified in the figure legends. Mouse erythrocyte membranes labeled 
with ~25I- in the presence of 0.05 % Triton X-100 and/or myosin, ~galac- 
tosidase, pbosphorylase B, BSA, ovalbumin, and carbonic arthydrase  were 
used as molecular mass markers. The gels were dried and autoradiographed 
at -70°C with an intensifying screen with either Kodak XAR or SB5 films 
(Eastman Kodak Co., Rochester, NY), as specified in the figure legends. 
Purification of the Fibronectin Receptor 
An octylglucoside cell extract (2 ml) from t25I surface-labeled MEL cells 
(108 cell equivalents) was chromatographed on 1-ml bed volume of wheat 
germ  agglutinin-agarose equilibrated  with  50  mM  NaCI,  10  mM  Na- 
phosphate, I mM CaCI2,  1 mM MgC12, 1 mM PMSF, and 50 mM octyl- 
glucoside (pH 7.4). After extensive washing of the column, bound material 
was eluted with 0.5 M N-acetylglucosamine in the same buffer, and loaded 
onto l-ml bed volume of DEAE-sepharose preequilibrated with 10 mM Na- 
phosphate, 1 mM CaClz,  1 mM MgCI2,  1 mM PMSE and 50 mM octyl- 
glucoside (pH 7.4).  After washing the column with the same buffer, bound 
material  was  eluted  with 0.17 M  NaC1,  10  mM  Na-phosphate,  1  mM 
CaCI2,  1 mM MgC12, 1 mM PMSE 50 mM octylglucoside (pH 7.4) and 
the eluate was loaded on an affinity matrix (l-ml bed volume) obtained by 
coupling the  ll5-kD  chymotryptic fragment of fibronectin to  cyanogen 
bromide-activated Sepharose 4B according to the manufacturer's instruc- 
tions (Pharmacia technical handbook, 1985). The column was washed with 
0.15 M NaCI,  10 mM Na-pbosphate, 1 mM CaC12, 1 mM MgCI2,  1 mM 
PMSE 50 mM octylglucoside (pH 7.4),  and the fibronectin receptor was 
eluted with a 1 mg/ml solution of the heptapepfide gly-arg-gly-asp-ser-pro- 
cys dissolved in the same buffer. The eluted material, which migrated as a 
broad band of ,x,140 kD on reducing gels, was concentrated by adsorption 
on wheat germ agglutinin-agarose and eluted with 1 rnl of 0.5 M N-acetyl- 
glucosamine. A 30-~tl aliquot of the eluate was mixed with an equal volume 
of double-strength Laemmli gel sample buffer and boiled for 3 min, while 
the remainder was immunoprecipitated with antifibronectin receptor anti- 
body (see Fig. 7). The antiserum was obtained by immunizing rabbits with 
the material eluted from the llS-kD Sepharose column after following the 
same protocol described above with unlabeled cells. 
For the experiment reported in Fig. 5, an octylglucoside cell extract (! 
ml each) from  ~25I surface-labeled Ba F3 and PD 31  cells (5  x  l0  7 cell 
equivalents) was chromatographed directly on 1-ml bed volume columns 
containing the ll5-kD fragment of fibronectin coupled to a Sepharose ma- 
trix. After washing with 7 ml of 0.15 M NaC1,  10 mM Na-phosphate, 1 mM 
CaCl2,  1 mM MgCI2,  1 mM PMSE 50 mM octylglucoside (pH 7.4),  the 
columns were sequentially eluted with 2 ml ofa 1 mg/ml solution of gly-arg- 
gly-glu-ser-pro peptide, 2.5 ml of a 1 mg/ml solution of gly-arg-gly-asp-ser- 
pro peptide, and finally 2 ml of 6 M urea, all in the above buffer.  Fractions 
of 0.5 ml were collected, and 40 ptl of each was mixed with an equal volume 
of double-strength Laemmli gel sample buffer,  boiled for 3 min, and sub- 
jected to  SDS-PAGE and autoradiography as specified in the legend to 
Fig. 5. 
Results 
Attachment of  Selected Lymphoid Lines to 
Fibronectin In Vitro 
Six cell lines of B lymphoid lineage blocked at specific stages 
of differentiation were screened for their ability to attach to 
fibronectin-coated dishes (Table I). Ba F3 is an interleukin 
3-dependent  clone that  is  positive  for the  B  lineage-re- 
stricted B220 antigen, and has the immunoglobulin genes in 
germline configuration. Clones with similar properties have 
been shown to undergo in vivo differentiation along the B lin- 
eage (Palacios and Steinmetz,  1985),  and therefore Ba F3 
likely represents a B stem cell. 38 B9 is an Abelson transfor- 
mant  derived from fetal  mouse  liver that  has  undergone 
heavy- but not light-chain gene rearrangement (Alt et al., 
1981). PD 31  is an Abelson-transformed cell line derived 
from adult mouse bone marrow that in vitro actively under- 
goes light-chain gene rearrangement (Lewis et al., 1982). 70 
Z/3 is a chemically transformed pre-B cell line that can be 
induced to express surface immunoglobulin in vitro (Paige 
et al.,  1978), whereas WEHI 231 is a lymphoma line consti- 
tutively expressing high levels of surface IgM (Ralph, 1979). 
MPC  11  is an IgG-producing mouse myeloma line (Kuehl 
and  Scharff,  1974). MEL  is  a  Friend  virus-transformed 
erythroleukemic line (Friend et al.,  1971), which was used 
here  as  a  positive  control,  in  that  it  expresses  a  well- 
characterized receptor for  fibronectin (Patel  and  Lodish, 
1984,  1986). 
The rationale for using these different lymphoid cell lines 
was to determine whether adhesion to fibronectin is develop- 
mentally regulated. Data in Table I and Fig.  1 suggest that 
adhesion  to  fibronectin decreases  with  differentiation.  A 
greater extent of adhesion (40-70%) was observed with the 
pre-B  lines,  whereas  the  WEHI  231  and  MPC  11  cells 
yielded the lowest values (20-30%) and B lymphocytes from 
peripheral blood did not adhere at all. Note that 70 Z/3 and 
WEHI 231  cells exhibited a  relatively high attachment to 
BSA-coated dishes, which contributes to an overestimation 
of the degree of adhesion to fibronectin inasmuch as albumin 
is used to block unspecific protein adsorption sites after coat- 
ing the dishes  with fibronectin. Attachment to fibronectin 
is specific, because neither laminin nor type I collagen pro- 
moted comparable levels of adhesion (not shown).  These 
findings suggest that the specific attachment to fibronectin is 
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Figure 1.  Dose-dependent at- 
tachment of selected cell lines 
to  fibronectin.  96-well  poly- 
styrene microtiter plates (Lin- 
bro)  were  coated  with  the 
indicated amounts of fibronec- 
tin,  and a  cell attachment as- 
say  carded  out  with  MEL 
(squares),  PD 31  (circles),  or 
MPC  11  (triangles)  ceils. 
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Figure 2. Effect of  antifibronectin antibodies and of a synthetic pep- 
tide on Ba F3 cell attachment to fibronectin. 96-well polystyrene 
plates were coated with 10 Ixg/cm  z fibronectin. (a) N-296 (tr/an- 
gles) or N-294 (circles) monoclonal antibodies were added, and the 
plate incubated for 1 h at 4°C before addition of Ba F3 cells. (b) 
The indicated concentrations of the synthetic peptide gly-arg-gly- 
asp-ser-pro-cys were added  immediately before the  addition of 
cells. 
higher in pre-B cells than in surface Ig-positive or Ig-produc- 
ing cells. 
The difference between the two groups was more striking 
if the assay was carried out in 96-well microtiter plates rather 
than in 35-mm diameter petri dishes. Fig.  1 shows that the 
pre-B line PD 31 exhibited a dose-dependent attachment to 
fibronectin, whereas the myeloma line MPC  U did not. A 
likely explanation is that the geometry of the vessel, and 
hence the hydrodynamic forces to which the cells are sub- 
jected during the washes, can cause decreased recovery of 
the adherent fraction. 
The fibronectin receptor of most cell types characterized 
thus far specifically recognizes and interacts with the arg- 
gly-asp fibronectin sequence contained in the cell-binding 
domain of the protein (reviewed by Ruoslahti and Piersch- 
bacher, 1986). Fig. 2 shows that ceils of the lymphoblastoid 
Ba F3 clone bind to the same domain of fibronectin.  Fig. 2 a 
shows that the monoclonal antibody N-294, directed against 
a pepsin cleavage site at the amino terminus of the ll.5-kD 
cell adhesion fragment of fibronectin, completely inhibited 
Ba F3  attachment,  whereas the N-296 antibody, which is 
directed against the carboxy terminus of fibronectin which 
contains the second fibrinogen-binding site, did not interfere 
even at 80 Itg/ml (not shown). Similar results were obtained 
with MEL cells (Patel and Lodish,  1986).  In keeping with 
these findings,  the  synthetic heptapeptide gly-arg-gly-asp- 
ser-pro-cys inhibited cell attachment to fibronectin in a dose- 
dependent fashion (Fig. 2 b) whereas a control gly-arg-glu- 
asp-ser-pro peptide was without effect (not shown). 
Lack of  Adhesion of  Committed Lymphoid Precursor 
Cell Lines to the Arg-Gly-Asp Signal, but Adhesion to 
the Carboxy-terminal Region of  Fibronectin 
Containing the High-affinity Heparin-binding Domain 
To further characterize the interaction of selected lymphoid 
lines with fibronectin, we tested the ability of Ba F3 and PD 
31  cells  to adhere to a  ll5-kD  chymotryptic fragment of 
fibronectin containing the arg-gly-asp cell attachment recog- 
nition sequence (Ruoslahti and Pierschbacher,  1986). 
Fig. 3 a shows that Ba F3 cells attached equally well to in- 
tact fibronectin and to its  llS-kD chymotryptic fragment, 
much like MEL cells, used here as a positive control (Fig. 
3 c). Interestingly, PD 31 cells attached to intact fibronectin 
but not to the llS-kD fragment (Fig. 3 b), suggesting that ei- 
ther these cells do not recognize the arg-gly-asp sequence or 
that they require additional  site(s)  for effective adhesion. 
This finding was confirmed unequivocally in assays in 35- 
nun dishes, and in experiments where [~4C]leucine-labeled 
PD 31  cells were plated together with [3H]leucine-labeled 
MEL cells (not shown). Results similar to PD 31 cells, not 
shown here, were obtained with the early pre-B line 38 B9, 
suggesting that this might be a more general feature of com- 
mitted B cells. 
To identify the region of the fibronectin molecule involved 
in the adhesion of PD 31 cells, we analyzed fragments from 
different regions of the fibronectin molecule for adhesion- 
promoting activity.  Dose-dependent attachment of PD  31 
cells was  promoted by a  preparation purified by heparin- 
Sepharose affinity chromatography of a chymotryptic digest 
of fibronectin (Fig. 4 a). A SDS-PAGE analysis of  this prepa- 
ration is shown in the inset to Fig. 4 a. Under reducing con- 
ditions (lane 1 ), four major polypeptides of 43, 32, 29, and 
17 kD were detected. Under nonreducing conditions (lane 
2), the 43- and 17-kD species migrated as a single band of 
55 kD, whereas the 29-32-kD doublet mobility was unaf- 
fected. Western blots of this preparation, not shown here, re- 
vealed that none of these fragments is  recognized by the 
N-294 monoclonal antibody. The 43-kD species is recog- 
nized by  antibody N-296  and  therefore encompasses  the 
carboxy-terminal end of fibronectin containing the second 
fibrin-binding  site.  Therefore we infer that the 29-32-kD 
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Figure 3. Adherence of selected cell lines to intact 
fibronectin or to  its  ll5-kD  chymotryptic frag- 
ment.  96-well polystyrene plates (Linbro) were 
coated with the indicated amounts of fibronectin 
(circles)  or  its  ll5-kD  chymotryptic  fragment 
(squares), and a cell-binding assay was carried out 
with (a) Ba F3, (b) PD 31, or (c) MEL cells. 
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binding fragment of fibronectin.  Lack of inhibition 
by heparin and by antifibronectin  antibodies.  96- 
well polystyrene plates were coated with (a) the in- 
dicated  amounts or (b and c) with 4  ~g/cm  2 of a 
heparin-binding  chymotryptic fragment of fibro- 
nectin.  A  cell-binding  assay  was carried out (a) 
with PD 31 cells without further additions or in the 
presence  of (b)  the  indicated  concentrations  of 
heparin  or  (c)  antifibronectin  monoclonal  anti- 
body N-296 (triangles) or N-294 (circles). The in- 
set  to panel  a  shows  a  Coomassie Blue-stained 
SDS-PAGE analysis of the heparin-binding  prepa- 
ration  on  a  5-15%  gradient  gel  under  (lane  1) 
reducing or (lane  2) nonreducing conditions.  K, 
Mr standards  in kilodaltons. 
doublet  is  part  of the  high-affinity  heparin-binding  site  of 
fibronectin,  and  is  located  between  the  carboxy-terminal 
fibrin-binding  site and the cell-binding  site. 
Fig. 4 also shows that adhesion of PD 31 cells to microtiter 
wells coated with this heparin-binding  preparation  was not 
inhibited  by either  heparin  (b)  or by the  N-294 or N-296 
antifibronectin  antibodies  (c).  Thus,  it seems unlikely that 
adhesion is mediated by surface heparan proteoglycans or by 
trace contaminants that derive  from the classical "arg-gly- 
asp" cell-binding domain. Rather, these experiments suggest 
that PD 31 cells express a fibronectin receptor with a differ- 
ent specificity. 
To test this hypothesis at the molecular level, we subjected 
extracts from surface-radioiodinated Ba F3 and PD 31 cells 
to affinity chromatography on a matrix obtained by coupling 
the  ll5-kD chymotryptic fibronectin fragment to Sepharose 
(Pytela et al.,  1985). Fig. 5 shows that the synthetic gly-arg- 
gly-asp-ser-pro peptide eluted a band of '~140 kD from Ba 
Figure 5. Autoradiograms of SDS-PAGE analyses of fractions obtained by affinity chromatography of cell extracts  from surface  radioiodi- 
natexl cells on the llS-kD chymotryptic fragment of fibronectin.  Extracts  from ~25I  surface-labeled  Ba F3 and PD 31 cells (1 ml) were pre- 
pared, and chromatographed on 1-ml bed volume columns obtained by coupling a llS-kD chymotryptic fragment of fibronectin to Sepharose 
4B.  After washing,  the columns were sequentially  eluted  (arrows) with  2 ml of a  1 mg/ml solution  of gly-arg-gly-glu-ser-pro peptide 
(GRGESP), 2.5 ml of a 1 mg/ml solution of gly-arg-gly-asp-ser-pro (GRGDSP) peptide,  and 2 ml of 6 M urea. Fractions of 0.5 ml were 
collected, and 40 ~tl of each analyzed on 7.5 % Laemmli gels under reducing conditions.  (A) Ba F3 cells;  (B) PD 31 cells.  In each panel: 
lane 1, flowthrough;  lane 2, last wash fraction before elution; lanes 3-6, elution with GRGESP peptide;  lanes  7-11, elution with GRGDSP 
peptide;  lanes 12-15, elution with urea.  The dried gels were exposed to Kodak XAR-5 film at -70°C with an intensifying  screen. Exposure 
time was 8 h for lane 1 (in each panel) and 4 d for lanes 2-15. Specific activity of the extracts was (trichloroacetic  acid-precipitable  counts 
x  txl-~): Ba F3, 94,400; PD 31, 85,100. K, Mr standards  in kilodaltons. 
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good agreement  with  the  cell  adhesion  experiments,  and 
strongly suggests that the putative fibronectin receptor of the 
committed lymphoid line PD 31 does not recognize the arg- 
gly-asp cell recognition sequence on fibronectin. 
Characterization  of  an Antiserum against the 
Fibronectin  Receptor of  Mouse Erythroleukemia Cells: 
Immunologic Cross-reactivity  with the Putative 
Lymphoid Receptor 
To further characterize the fibronectin receptor(s) of mouse 
erythroleukemia cells (Patel  and Lodish,  1984,  1986)  and, 
we  hoped,  of B  cells,  an  antiserum  against  the  affinity- 
purified erythroid fibronectin receptor was raised in rabbits. 
Fig. 6  shows that a purified Ig fraction of this antiserum in- 
hibited attachment of MEL cells (a), Ba F3 cells (b), and PD 
31 cells (c) to fibronectin, whereas preimmune Ig were with- 
out effect. Even though in the case of PD 31 cells the degree 
of inhibition was lower and a  higher concentration of anti- 
body was required,  these results were reproducible. 
To identify cell surface components recognized by this an- 
tiserum,  a  detergent  extract  of  ~25I surface-labeled  MEL 
cells was prepared; part was immunoprecipitated with either 
preimmune or with antifibronectin receptor serum, while the 
remainder was subjected to an affinity chromatography puri- 
fication  procedure  as  detailed  in  Materials  and  Methods 
(Patel and Lodish, 1986). As shown in Fig. 7, the specific im- 
munoprecipitates from the total cell extract (lane 3) and the 
affinity-purified receptor (lane 5) contained the 140-kD pro- 
tein  characterized  previously  as  the  erythroid  fibronectin 
receptor (lane 4) (Patel and l_~dish,  1986). Note that the im- 
munoprecipitate from the total cell extract (lane 3) appears 
to migrate slightly  faster than the affinity-purified receptor 
(lanes 4 and 5). This might be due to limited proteolysis of 
the labeled protein during incubation of the total cell extract 
with  antibody.  Alternatively,  the  radioactive  iodine  might 
have labeled a lower molecular mass precursor form of the 
receptor  in  a  small  number of permeable  cells.  Since the 
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Figure 6. Inhibition of cell at- 
tachment to fibronectin by an- 
tibodies against the fibronectin 
receptor  of MEL  cells.  96- 
well  polystyrene plates  were 
coated with  (a)  5  ~tg/cm  2 or 
(b and c)  10 Ixg/cm: of fibro- 
nectin. (a) MEL, (b) Ba F3, or 
(c)  PD  31  cells  were  pre- 
incubated  for 1 h at 0°C with 
the  indicated  concentrations 
of a purified  Ig fraction from 
rabbit  sera  obtained  before 
(open circles) or after (solid 
circles) immunization  with af- 
finity-purified  fibronectin  re- 
ceptor from MEL cells. 
Figure 7. Autoradiogram of a SDS-PAGE analysis  of immunopre- 
cipitates  obtained  from total cell extracts  or from affinity-purified 
fibronectin receptor with an antiserum against the MEL fibroneetin 
receptor.  Extracts  from 1251 surface-labeled  MEL and Ba F3 cells 
were prepared, and the same number of cell equivalents was immu- 
noprecipitated  with rabbit serum obtained before or after immuni- 
zation with purified  fibmnectin receptor from MEL cells.  Part of 
the same MEL extract  was used to afffinity-purify the fibronectin 
receptor, which was then immunoprecipitated  with immune serum. 
Samples  were analyzed by SDS-PAGE on a 7.5 % polyacrylamide 
gel under reducing conditions.  Lanes 1-5, MEL cells:  lane 1, total 
cell  extract;  lane  2,  immunoprecipitate  of total  cell  extract  with 
preimmune serum; lane 3, immunoprecipitate  of total cell extract 
with immune serum; lane 4, affinity-purified  fibronectin  receptor; 
lane 5, immunoprecipitate  of affinity-purified  fibronectin  receptor 
with immune serum. Lanes 6-8, Ba F3 cells:  lane 6, total cell ex- 
tract; lane  7,  immunoprecipitate  of total cell extract  with preim- 
mune serum; lane 8, immunoprecipitate  of total cell extract  with 
immune serum. The dried gel was exposed to Kodak XAR film for 
5  d  at  -70°C  with  an  intensifying  screen.  K,  Mr  standards  in 
kiiodaltons. 
precursor does not bind to the ll5-kD Sepharose affinity ma- 
trix but is recognized by this antibody (V.  P.  Patel,  unpub- 
lished),  the  immunoprecipitate  from the  total  cell  extract 
could be expected to appear broader. A  protein of '~140 kD 
was also immunoprecipitated with immune serum from a de- 
tergent extract from 1251 surface-labeled Ba F3 cells (lane 8) 
and  from affinity-purified  Ba  F3  fibronectin  receptor  (not 
shown),  suggesting  that  the  adhesion  of Ba  F3  cells  to 
fibronectin was mediated by a  similar receptor.  In addition 
to the 140-kD protein, a second major protein of 70 kD was 
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was  not  present  in  the  RGD  eluate  from  the  fibronectin 
affinity column (Fig.  5 a,  lanes  7-11). Whether these pro- 
teins are functionally related, or whether the lower molecu- 
lar mass form is a proteolytic product is unclear at present. 
In any case, the availability of the antifibronectin receptor an- 
tiserum allowed us to  screen a  large number of lymphoid 
lines for the presence of related surface molecules. 
Immunoprecipitation  of ~I Surface-labeled Lymphoid 
Cell Extracts with Antifibronectin Receptor Serum 
To test whether cells of B lineage express proteins immuno- 
logically related to the erythroid fibronectin receptor, we im- 
Figure 8.  Autoradiogram  of a  SDS-PAGE analysis  of immuno- 
precipitates  from selected lymphoid lines with antifibronectin re- 
ceptor antiserum.  Extracts from 5  x  107 ~25I surface-labeled cells 
were prepared,  and identical aliquots (0.5 ml) immunoprecipitated 
with either preimmune or immune serum against the MEL fibro- 
nectin receptor.  The samples were analyzed by SDS-PAGE on a 
7.5 % polyacrylamide gel under reducing conditions. Lanes 1-4, to- 
tal cell extracts (2.5  x  105 cell equivalents); lanes 5-8,  immuno- 
precipitates  with preimmune  serum (from 2.5  x  107 cell equiva- 
lents); lanes 9-12, immunoprecipitates with immune serum (from 
2.5  x  107 cell equivalents).  Lanes 1, 5, and 9, Ba F3 cells; lanes 
2, 6, and 10, 38 B9 cells; lanes 3,  7, and//, PD 31 cells; lanes 4, 
8, and 12, MPC  11 cells. The dried gel was exposed to Kodak SB5 
film for 52 h at -70°C with an intensifying screen. Specific activity 
of the  extracts  was  (trichloroacetic  acid-precipitable  counts  x 
gl-~): Ba  F3,  78,400; 38  B9,  41,700; PD  31,  54,600;  MPC  11, 
73,600. K, Mr standards  in kilodaltons. 
munoprecipitated with  the  antifibronectin  receptor antise- 
rum extracts  from selected,  125I surface-labeled cell lines. 
Fig. 8 illustrates the results we obtained with Ba F3, 38 B9, 
and PD 31, which adhere to fibronectin, and MPC 11, which 
does not. Ba F3 cells (lane 9) showed two major bands simi- 
lar to those described in Fig. 7, lane 8,  whereas 38 B9 and 
PD 31  cells exhibited two major bands of 140 and  120 kD, 
and a minor component of higher molecular mass (lanes 10 
and//).  None of these proteins was present in the precipi- 
tates with preimmune serum (lanes 5-8). On the other hand, 
the  immune  serum precipitated  no  species  from MPC  11 
cells (lane 12) that were not precipitated by preimmune se- 
rum (lane 8). In the experiment described in Fig. 8, the high 
molecular mass species of Ba F3 cells showed a faster mobil- 
ity on the SDS-PAGE gel than did the  140-kD species from 
38 B9 and PD 31 cells. This may be due to differences in pro- 
tein glycosylation, since digestion of Ba F3 and PD 31  im- 
munoprecipitates  with N-glycanase  (but  not  O-glycanase) 
produced a shift of the 140- and 120-kD proteins to a single 
band  of  ,MOO kD  (not  shown).  The  absence  of reactive 
material in MPC  11  cells was not due to differences in the 
specific activity of the  radioiodinated  extracts,  because in 
this particular experiment the specifc activity of the Ba F3 
and MPC  11 extracts was the same, and about twice that of 
38 B9 and PD 31 cells (compare also lanes 1-4). Thus, this 
myeloma line did not attach to fibronectin and did not ex- 
press  proteins  specifically  recognized  by  the  antiserum 
against the erythroid fibronectin receptor. On the other hand, 
the Ba F3, 38 B9,  and PD 31 lines, which adhered to fibro- 
nectin,  expressed species that are immunologically cross- 
reactive with the erythroid receptor molecule. 
Fig. 9 compares the electrophoretic pattern ofimmunopre- 
cipitates from ~25I surface-labeled Ba F3, 38 B9,  and PD 31 
cells under reducing and nonreducing conditions in separate 
9 % polyacrylamide gels. Under reducing conditions, the Ba 
F3 cells exhibited the 140- and 70-kD proteins (lane 4), and 
38 B9 and PD 31 displayed three bands of 180, 140, and 120 
kD (lanes 5 and 6, a-c). The 140- and 120-kD species (b and 
c) were always detected in repeats of this experiment, while 
the  180-kD species (a) was not, and its origin is unclear at 
present.  Under nonreducing conditions there was a definite 
difference in mobility: a major, broad band (arrow) was de- 
tected in 38 B9 and PD 31 immunoprecipitates (lanes 2 and 
3), which migrated near the higher molecular mass species 
from Ba F3 cells (lane 1).  These results were confirmed in 
a  similar experiment where  the  immunoprecipitates were 
analysed on the same 7.5 % polyacrylamide gel (not shown). 
Normal Bone Marrow Pre-B Cells Adhere to 
Fibronectin and to Its Heparin-binding Fragment 
in  Vitro 
Expression of cell surface receptors mediating adhesion to 
fibronectin is a  remarkable feature of these transformed B 
cell lines that are adapted to growth in suspension culture. 
To determine whether this property is related to the trans- 
formed phenotype, or whether these cells were constitutively 
expressing the receptor molecules when the transformation 
event(s) occurred,  we have extended  our analysis to  cells 
from normal bone marrow, which is the site of maturation 
of lymphocytes in the adult mammal (Osmond and Nossal, 
1974; Osmond,  1975). We prepared a  fraction enriched  in 
mononuclear cells by density gradient centrifugation,  and 
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cipitates from selected lymphoid lines with antifibronectin receptor 
serum. Comparison between reducing and nonreducing conditions. 
Extracts  from ~25I surface-labeled  ceils were immunoprecipitated 
with antifibronectin receptor serum. The immunoprecipitates were 
dissolved in gel sample buffer and divided into two identical ali- 
quots, one of  which was reduced with 2-mercaptoethanol. The sam- 
ples were boiled for 3 min and subjected to SDS-PAGE on separate 
9.0% polyacrylamide  gels.  Lanes  1-3, unreduced  samples;  lanes 
4-6, reduced samples. Lanes 1 and 4, Ba F3 cells; lanes 2 and 5, 
38 B9 cells; lanes 3 and 6, PD 31 cells. The dried gels were exposed 
to Kodak XAR film for 23 h at -70°C with an intensifying screen. 
o, origin of gels. K, Mr standards in kilodaltons. 
this fraction was depleted of monocytes and macrophages by 
adherence to tissue culture grade plastic dishes. This prepa- 
ration is enriched in cells of B  lineage, in that 40-50%  of 
the  cells  were  positive  for  the  antigen  B220,  which  is  a 
B-restricted  antigen  expressed throughout the  life cycle of 
these cells (Coffman, 1982).  Table II shows that 55% of the 
B220-positive cells and 26 % of the surface Ig-positive cells 
adhered to intact fibronectin, whereas 94 % of the B220-pos- 
itive cells and 92 % of the surface Ig-positive cells adhered 
to the heparin-binding fragment of fibronectin. Why a popu- 
lation of bone marrow cells adheres to the heparin-binding 
fragment but not to intact fibronectin is unclear at present, 
but even with PD 31  cells we have routinely observed that 
a larger number of cells adhere to the heparin-binding frag- 
ment. Attachment of bone marrow pre-B cells to fibronectin 
was specifc, in that they did not adhere to either laminin or 
collagen type I, nor did they show an increased attachment 
on a combination of fibronectin and collagen (not shown). 
Because circulating B lymphocytes do not adhere to fibro- 
nectin (Table I), although a fraction of pre-B and B cells from 
the bone marrow do (Table II), we conclude that differentia- 
tion of bone marrow pre-B cells into B  lymphocytes is ac- 
companied by a loss of adhesion to fibronectin. Whether the 
adhesion of normal bone marrow cells to fibronectin is medi- 
ated by the same molecule(s), we characterized in the trans- 
formed lymphoid cell lines remains to be established. 
Discussion 
We have shown that several B lymphoid cell precursor lines, 
blocked at specific stages of differentiation, specifically ad- 
here to fibronectin in an in vitro assay. Whereas Ba F3 cells, 
presumably a B stem cell (Palacios and Steinmetz, 1985), ad- 
here to the classical cell attachment domain of fibronectin, 
the B-committed line PD 31  does not.  Rather,  adhesion of 
PD 31 cells is mediated by a different region of the fibronec- 
tin molecule, which is part of the carboxy-terminal region 
containing the high-affinity binding site for heparin. An anti- 
body  raised  against  the  fibronectin  receptor  of  mouse 
erythroleukemic  cells  inhibits  lymphoid  cell  adhesion  to 
fibronectin, and precipitates surface proteins of 140 and 70 
kD from surface-radioiodinated Ba F3 cells and of 140 and 
120 kD from B-commit~i cells. Based on this evidence, we 
propose that  these  cell  lines  express  different  fibronectin 
receptors that mediate substrate adhesion,  and suggest that 
a receptor with different specificity might be expressed in the 
course of B cells maturation. Because a large proportion of 
mouse bone marrow cells of B lineage specifically adhere to 
fibronectin and to this heparin-binding fragment in vitro, we 
infer  that  these  proteins  might  play  a  role  in  lymphoid 
precursor cell adhesion to the extracellular matrix. 
The fibronectin receptor of Ba F3 cells belongs to the fam- 
ily of receptors that recognize the arg-gly-asp sequence on 
the cell-binding domain of fibronectin (reviewed by Ruos- 
lahti and Pierschbacher,  1986).  Indeed, Ba F3 cells adhere 
to both intact fibronectin and to its llS-kD chymotryptic frag- 
ment that contains the cell binding site (Fig. 3 a). Attachment 
to  fibronectin is  inhibited  by both a  monoclonal antibody 
(N-294)  directed  against the cell-binding domain of fibro- 
nectin and by a heptapeptide containing the arg-gly-asp cell 
attachment  recognition  sequence  of fibronectin  (Fig.  2). 
They  also  possess  a  140-kD  cell  surface  protein  that  is 
specifically bound by the affinity matrix containing the  115 
kD cell-binding fragment of fibronectin, and is specifically 
Table II. Adhesion of  Bone Marrow Cells to Intact 
Fibronectin and to Its Heparin-binding Fragment 
Adherent cells 
Heparin-binding 
Cell type  Fibronectin  fragment  BSA 
% 
Total population  48  78  4 
B  220 positive cells  55  94  ND 
Surface Ig positive cells  26  92  ND 
As detailed  in Materials  and  Methods,  we prepared  a population  of mono- 
nuclear bone marrow cells depleted of monocytes/macrophages.  These were 
assayed  for attachment  to  fibronectin  (20  gg/cm2),  to  its  carboxy-terminal 
heparin-binding  fragment  (5  Ixg/cm2), or to BSA (2%)  on 60-ram diameter 
plastic petri dishes. The attached and unattached populations were then stained 
with either anti-B220 or anti-Ig antibodies. Of the cells used in this assay 49% 
were B220 positive and 20% were positive for surface Ig. ND, not determined. 
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asp sequence (Fig. 5 a). This protein has,  therefore, all of 
the properties of a cell surface fibronectin receptor. 
At variance from MEL and Ba F3  cells, the B  lineage- 
committed PD 31 cells adhere to intact fibronectin but not 
to its ll5-kD chymotryptic fragment that contains the classi- 
cal cell-binding site of fibronectin (Fig. 3 b).  Accordingly, 
they have no specific surface protein that could be eluted 
from an affinity matrix containing the ll5-kD chymotryptic 
fragment of fibronectin (Fig. 5 b). PD 31 cells do adhere to 
chymotryptic fragments of fibronectin purified by affinity 
chromatography on heparin-Sepharose (Fig. 4 a); adhesion 
is not inhibited either by a 20-fold excess of heparin (Fig. 4 
b) or the fibronectin monoclonal antibodies N-294 or N-296 
(Fig. 4 c). Although the heparin-binding preparation is not 
purified to homogeneity, we are confident that adhesion of 
PD 31 cells to these peptides does not involve interactions 
with the classical arg-gly-asp sequence, and is probably not 
mediated by cell surface-associated heparan sulphate pro- 
teoglycans. Thus, we conclude that one or more surface mol- 
ecules on PD 31 cells are receptors that bind to a different 
region of fibronectin. 
Adhesion to the heparin-binding domain of fibronectin is 
not restricted to PD 31 cells, in that these heparin-binding 
fragments of fibronectin also promote adhesion of Ba F3, 
MEL  cells,  and  normal  rat  kidney  fibroblasts  (data  not 
shown). Thus, even cells with a classical fibronectin receptor 
recognize, in addition, a different region of the fibronectin 
molecule. These data are consistent with recent evidence that 
the heparin-binding region of the fibronectin molecule medi- 
ates important biologic effects both in fibroblasts (Woods et 
al.,  1986) and in melanoma cells (McCarthy et al.,  1986). 
Indirect evidence for a receptor-mediated process in the 
interaction  of lymphoid  precursor  cells  with  fibronectin 
comes from the studies with an antiserum raised against the 
erythroid fibronectin receptor. Immunoglobulins in this an- 
tiserum,  but not in preimmune serum,  block adhesion of 
MEL and Ba F3 cells to fibronectin-coated wells (Fig. 6, a 
and b). The same antibody immunoprecipitates a major pro- 
tein of ~140 kD from both a total cell extract or an affinity- 
purified fibronectin receptor preparation from surface radio- 
iodinated MEL cells  (Fig.  7),  proving that it specifically 
recognizes the  fibronectin receptor.  A  similar experiment 
with Ba F3 cells gave identical results (not shown), suggest- 
ing that the surface molecules recognized by this antibody in 
cells of B lineage define their receptor for fibronectin. Inas- 
much  as  the  antiserum  against  the  erythroid  fibronectin 
receptor also  inhibits  attachment of PD  31  cells to intact 
fibronectin (Fig.  6  c)  and  immunoprecipitates two major 
polypeptides of 140 and 120 kD from surface-labeled PD 31 
and 38 B9 cells (Figs. 8 and 9), we suspect that these poly- 
peptides are the fibronectin receptor(s) of  these B-committed 
lymphoid lines  and  that  they are  immunologically cross- 
reactive with but not identical to the erythroid and Ba F3 cell 
receptors. Some support for our hypothesis comes from the 
results obtained with the mouse plasmocytoma line MPC 11. 
These cells do not adhere to fibronectin (Table I and Fig. 1), 
and bear little, if any,  surface proteins that are specifically 
immunoprecipitated by the antiserum against the fibronectin 
receptor (Fig. 8). Whether our inability to detect a species 
cross-reacting with a fibronectin receptor in MPC  11 cells 
reflects a  property of the normal plasma  cell or is  rather 
linked  to  neoplastic  transformation  remains  to  be  estab- 
lished. 
Increasing evidence suggests that the "fibronectin recep- 
tors" are members of a large family of related but different 
proteins mediating cell interactions with several extracellu- 
lar components. Thus, the platelet IIb/IIIa glycoprotein com- 
plex,  which  mediates platelet  interaction with  fibronectin 
(Ginsberg et al.,  1985),  vitronectin (Pytela et al.,  1986), 
fibrinogen (Bennett and Vilaire, 1982), and von Willebrandt 
factor (Ruggeri et al.,  1982),  shares antigenic determinants 
with the fibronectin receptor of neutrophils and monocytes 
(Burns et al., 1986) and with endothelial cell membrane pro- 
teins  (Fitzgerald  et  al.,  1985;  Thiagarajan  et  al.,  1985). 
These homologies have recently been found to extend to two 
leukocyte  surface  glycoproteins,  Mac-1  (Springer  et  al., 
1979) and lymphocyte function-associated antigen-1  (LFA-1) 
(Davignon et al.,  1981), which are encoded by the same 20- 
kb genomic clone encoding platelet IIb/IIIa (Cosgrove et al., 
1986). These surface proteins consist of at least two subunits 
that  undergo  characteristic  changes  of mobility on  SDS- 
PAGE, depending on whether reducing or nonreducing con- 
ditions are used. Under nonreducing conditions, indeed, the 
larger subunit migrates at a  slower rate while the smaller 
subunit migrates faster (see, e.g., Pytela et al.,  1985, 1986; 
Burns et al.,  1986;  Patel and Lodish,  1986).  This is most 
likely due to the presence of intrachain disulfide bonding in 
cysteine-rich regions of the molecule, as convincingly de- 
duced from the cDNA sequence of the smaller subunit of the 
chicken fibroblast protein complex, integrin (Tamkun et al., 
1986). In the case of the lymphoid surface molecules charac- 
terized here, under nonreducing conditions we could not de- 
tect an increased mobility on SDS-PAGE analysis (Fig. 9). 
Whether this finding is due to a structural difference of the 
lymphoid receptor(s) remains to be established. 
B220 is an early B lineage-restricted antigen defined by the 
monoclonal  antibody  RA3-6B2  (Coffman,  1982).  About 
50%  of the B220 positive cells of a  mouse bone marrow 
preparation, enriched in lymphoid precursors, exhibit spe- 
cific attachment to fibronectin and a even higher percentage 
adheres to a heparin-binding fragment of fibronectin in vitro 
(Table II). This is also the case with surface Ig-positive cells 
of the bone marrow (Table II). We do not know whether in- 
creased adhesion of lymphoid cells to the heparin-binding 
fragments of fibronectin reflects an altered conformation of 
the fibronectin molecule caused by the chymotrypsin treat- 
ment or a  specific, developmentally regulated event.  This 
question can be addressed experimentally. The function of 
multiple  fibronectin receptors  with  different specificities, 
which are apparently expressed at different stages of B cell 
differentiation, might be involved in the migration of cells 
within the bone marrow. Expression of fibronectin receptors 
on lymphoid cells might also serve to anchor these cells to 
the fibronectin matrix of the bone marrow and prevent their 
premature release into the bloodstream. Because, however, 
peripheral blood lymphocytes do not adhere to fibronectin 
(Table I), surface fibronectin receptors of pre-B cells must 
be lost or modified at the terminal stages of development. It 
will be of interest to determine whether the released cells 
reacquire their ability to adhere to fibronectin in the process 
of homing into the peripheral lymphoid organs. 
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